SMS 201-995 belongs to somatostatin analog that is three times more potent than the native hormone in inhibiting the secretion of growth hormone. SMS 201-995 can lower plasma concentrations of growth hormone and somatomedin-C in patients with pituitary acromegaly. Somatostatin analogues have been suggested as possible therapy for human pancreatic cancer.